 The production of antibodies has become more complex due to increased demand for high-quality products. Variations in impurities present a challenge for process development and optimization, requiring new strategies such as adapting existing unit operations, exploring alternative separation technologies, and developing new methods. This article was authored by Patrick Rohmeyer, Reinhard Ditz, and Johann Strube.